{
    "2021-02-26": [
        [
            {
                "time": "",
                "original_text": "上海医药入股威斯克生物后，股价大涨，后者涉及新冠疫苗研发",
                "features": {
                    "keywords": [
                        "上海医药",
                        "威斯克生物",
                        "新冠疫苗",
                        "股价大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】上海医药(02607-HK)涨6.93%",
                "features": {
                    "keywords": [
                        "异动股",
                        "上海医药",
                        "涨幅"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "入股疫苗研发生产公司上海医药A股逼近涨停H股涨超7%",
                "features": {
                    "keywords": [
                        "入股",
                        "疫苗研发",
                        "上海医药",
                        "A股",
                        "H股"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药入股威斯克生物，后者为疫苗研发生产和免疫治疗公司",
                "features": {
                    "keywords": [
                        "上海医药",
                        "威斯克生物",
                        "疫苗研发",
                        "免疫治疗"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}